End-of-day quote
Korea S.E.
06:00:00 2024-05-02 pm EDT
|
5-day change
|
1st Jan Change
|
78,700
KRW
|
-0.25%
|
|
-0.63%
|
-0.13%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
80,563
|
95,836
|
179,336
|
350,745
|
254,666
|
182,457
|
Enterprise Value (EV)
1 |
96,523
|
134,787
|
228,923
|
425,053
|
352,470
|
280,757
|
P/E ratio
|
8.32
x
|
6.24
x
|
10.2
x
|
10.6
x
|
12.6
x
|
13.8
x
|
Yield
|
1.16%
|
0.97%
|
0.65%
|
0.33%
|
0.64%
|
-
|
Capitalization / Revenue
|
0.57
x
|
0.51
x
|
0.62
x
|
0.83
x
|
0.51
x
|
0.41
x
|
EV / Revenue
|
0.68
x
|
0.72
x
|
0.79
x
|
1.01
x
|
0.71
x
|
0.63
x
|
EV / EBITDA
|
18.3
x
|
12.4
x
|
8
x
|
11.9
x
|
12.2
x
|
12.1
x
|
EV / FCF
|
16.8
x
|
-6.23
x
|
13.7
x
|
51.3
x
|
-24.9
x
|
-206
x
|
FCF Yield
|
5.95%
|
-16.1%
|
7.29%
|
1.95%
|
-4.01%
|
-0.49%
|
Price to Book
|
0.61
x
|
0.65
x
|
1.1
x
|
1.73
x
|
1.15
x
|
0.78
x
|
Nbr of stocks (in thousands)
|
2,332
|
2,332
|
2,320
|
2,315
|
2,315
|
2,315
|
Reference price
2 |
34,550
|
41,100
|
77,300
|
151,500
|
110,000
|
78,800
|
Announcement Date
|
3/19/19
|
3/17/20
|
3/19/21
|
3/23/22
|
3/22/23
|
3/21/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
141,971
|
188,377
|
288,971
|
421,386
|
499,293
|
443,162
|
EBITDA
1 |
5,282
|
10,860
|
28,604
|
35,824
|
28,815
|
23,120
|
EBIT
1 |
3,613
|
7,764
|
21,798
|
29,724
|
22,841
|
15,564
|
Operating Margin
|
2.54%
|
4.12%
|
7.54%
|
7.05%
|
4.57%
|
3.51%
|
Earnings before Tax (EBT)
1 |
13,188
|
20,248
|
30,303
|
51,974
|
25,036
|
16,590
|
Net income
1 |
9,687
|
15,368
|
17,556
|
33,137
|
20,181
|
13,215
|
Net margin
|
6.82%
|
8.16%
|
6.08%
|
7.86%
|
4.04%
|
2.98%
|
EPS
2 |
4,155
|
6,591
|
7,557
|
14,308
|
8,717
|
5,708
|
Free Cash Flow
1 |
5,741
|
-21,634
|
16,686
|
8,283
|
-14,136
|
-1,364
|
FCF margin
|
4.04%
|
-11.48%
|
5.77%
|
1.97%
|
-2.83%
|
-0.31%
|
FCF Conversion (EBITDA)
|
108.68%
|
-
|
58.34%
|
23.12%
|
-
|
-
|
FCF Conversion (Net income)
|
59.26%
|
-
|
95.05%
|
25%
|
-
|
-
|
Dividend per Share
2 |
400.0
|
400.0
|
500.0
|
500.0
|
700.0
|
-
|
Announcement Date
|
3/19/19
|
3/17/20
|
3/19/21
|
3/23/22
|
3/22/23
|
3/21/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
15,960
|
38,951
|
49,587
|
74,307
|
97,803
|
98,300
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.022
x
|
3.587
x
|
1.734
x
|
2.074
x
|
3.394
x
|
4.252
x
|
Free Cash Flow
1 |
5,741
|
-21,634
|
16,686
|
8,283
|
-14,136
|
-1,364
|
ROE (net income / shareholders' equity)
|
7.66%
|
9.87%
|
12%
|
18.5%
|
10.8%
|
6.48%
|
ROA (Net income/ Total Assets)
|
1.17%
|
1.81%
|
4.22%
|
4.9%
|
3.13%
|
2.04%
|
Assets
1 |
827,646
|
850,688
|
416,494
|
676,079
|
645,117
|
647,627
|
Book Value Per Share
2 |
56,573
|
62,937
|
70,128
|
87,327
|
95,466
|
100,783
|
Cash Flow per Share
2 |
5,298
|
6,431
|
6,156
|
6,034
|
4,050
|
5,151
|
Capex
1 |
1,616
|
1,040
|
3,275
|
3,462
|
26,592
|
18,507
|
Capex / Sales
|
1.14%
|
0.55%
|
1.13%
|
0.82%
|
5.33%
|
4.18%
|
Announcement Date
|
3/19/19
|
3/17/20
|
3/19/21
|
3/23/22
|
3/22/23
|
3/21/24
|
|
1st Jan change
|
Capi.
|
---|
| -0.13% | 134M | | +16.74% | 65.38B | | +0.11% | 47.8B | | +16.88% | 40.65B | | +23.50% | 26.69B | | +12.85% | 19.24B | | +5.07% | 17.75B | | -21.87% | 16B | | -7.33% | 15.37B | | +3.47% | 15.23B |
Other Specialty Chemicals
|